Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-10-07-11-17-20-686-68e4f6c0760e4a634359f1e0.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-07-09-14-28-47-343-686e7c9fd11acb40859aa4e9.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-09-22-15-24-01-000-68d16a11ec772d3acc1595a3.png)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-09-16-10-18-50-245-68c9398a150ac484ced6193d.jpg)